l 680833 has been researched along with beta-lactams in 1 studies
Studies (l 680833) | Trials (l 680833) | Recent Studies (post-2010) (l 680833) | Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) |
---|---|---|---|---|---|
5 | 0 | 0 | 7,579 | 179 | 3,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brause, K; Chandler, GO; Doherty, JB; Dorn, CP; Finke, PE; Hagmann, WK; Hale, JJ; Kissinger, AL; Shah, SK; Thompson, KR | 1 |
1 other study(ies) available for l 680833 and beta-lactams
Article | Year |
---|---|
Chemical, biochemical, pharmacokinetic, and biological properties of L-680,833: a potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; beta-Lactams; Biological Availability; Calcimycin; Cricetinae; Fibrinogen; Hemorrhage; Humans; Lactams; Leukocyte Elastase; Lung Diseases; Macaca mulatta; Mice; Molecular Sequence Data; Molecular Structure; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pancreatic Elastase; Peptide Fragments; Phenylacetates; Rats; Structure-Activity Relationship | 1993 |